Treating inflammatory bowel disease with live bacteria
This invention relates to using live beneficial bacteria for treating inflammatory bowel disease, such as ulcerative colitis and Crohn's disease.
1. A method of treating an inflammatory bowel disease, comprising:
identifying a subject in need thereof, and
administering to the subject a composition which contains an effective amount of Clostridium butyricum CGMCC No. 0313.1.
2. The method of claim 1 , wherein the inflammatory bowel disease is Crohn's disease.
3. The method of claim 2 , wherein the composition contains an effective amount of Clostridium butyricum CGMCC No. 0313.1.
4. The method of claim 3 , wherein the composition contains 1 ×10 6 colony forming unit/g to 1 ×10 12 colony forming unit/g Clostridium butyricum CGMCC No. 0313.1.
5. The method of claim 1 , wherein the composition contains an effective amount of Clostridium butyricum CGMCC No. 0313.1.
6. The method of claim 1 , wherein the inflammatory bowel disease is ulcerative colitis.
7. The method of claim 6 , wherein the composition contains an effective amount of Clostridium butyricum CGMCC No. 0313.1.
8. The method of claim 7 , wherein the composition contains 1 ×10 6 colony forming unit/g to 1 ×10 12 colony forming unit/g Clostridium butyricum CGMCC No. 0313.1.
9. The method of claim 1 , wherein the effective amount of Clostridium butyricurn CGMCC No. 0313.1 is within the range of 1 ×10 6 to 1 ×10 12 colony forming unit per day.
10. The method of claim 1 , wherein the composition is administered orally.
11. The method of claim 1 , wherein the composition is a pharmaceutical composition.
12. The method of claim 11 , wherein the pharmaceutical composition is formulated in a form of tablet, capsule, powder, or liquid.
13. The method of claim 11 , wherein the pharmaceutical composition contains 1 ×10 6 colony forming unit/g to 1 ×10 12 colony forming unit/g live beneficial bacteria.
14. The method of claim 1 , wherein the composition is a food product or a food supplement.